Nissan North America, Inc.
Summary
NHTSA campaign 23V268: Nissan North America, Inc. recalled for a safety defect. An unsecured seat with broken welds may not properly restrain an occupant during a crash, increasing the risk of injury.
Details
Source
nhtsa
External ID
23V268
Action Date
2023-04-14
Status
Ongoing
Category
vehicle
Product Description
Nissan North America, Inc. (Nissan) is recalling certain 2023 Rogue, Pathfinder, and Infiniti QX60 vehicles. The driver's powered seat may not be fully secured to the seat frame, causing the seat frame welds to detach from the rear inboard seat bracket.
Company
Context & Analysis
Nissan North America, Inc. has 85 FDA actions in our database.
Frequently Asked Questions
How often does Nissan North America, Inc. have FDA actions?
Nissan North America, Inc. has 85 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle